Documents
Application Sponsors
NDA 022500 | TRIS PHARMA INC | |
Marketing Status
Discontinued | 001 |
Discontinued | 002 |
Application Products
001 | TABLET, EXTENDED RELEASE;ORAL | EQ 0.17MG BASE | 0 | CLONIDINE | CLONIDINE |
002 | TABLET, EXTENDED RELEASE;ORAL | EQ 0.26MG BASE | 0 | CLONIDINE | CLONIDINE |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 2009-12-03 | STANDARD |
Submissions Property Types
CDER Filings
TRIS PHARMA INC
cder:Array
(
[0] => Array
(
[ApplNo] => 22500
[companyName] => TRIS PHARMA INC
[docInserts] => ["",""]
[products] => [{"drugName":"CLONIDINE","activeIngredients":"CLONIDINE","strength":"EQ 0.17MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"CLONIDINE","activeIngredients":"CLONIDINE","strength":"EQ 0.26MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"09\/23\/2010","submission":"SUPPL-1","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/022500s001lbl.pdf\"}]","notes":""},{"actionDate":"12\/03\/2009","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/022500lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"CLONIDINE","submission":"CLONIDINE","actionType":"EQ 0.17MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"CLONIDINE","submission":"CLONIDINE","actionType":"EQ 0.26MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 2010-09-23
)
)